MARKET

LAB

LAB

STANDARD BIOTOOLS INC
NASDAQ
1.110
-0.080
-6.72%
After Hours: 1.120 +0.01 +0.90% 19:30 02/12 EST
OPEN
1.220
PREV CLOSE
1.190
HIGH
1.220
LOW
1.100
VOLUME
2.00M
TURNOVER
--
52 WEEK HIGH
1.720
52 WEEK LOW
0.9200
MARKET CAP
426.87M
P/E (TTM)
-3.2811
1D
5D
1M
3M
1Y
5Y
1D
Standard BioTools Inc.'s (NASDAQ:LAB) Popularity With Investors Under Threat As Stock Sinks 27%
Simply Wall St · 17h ago
Standard BioTools Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results
Reuters · 2d ago
Standard BioTools Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht
Reuters · 2d ago
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Barchart · 2d ago
Weekly Report: what happened at LAB last week (0202-0206)?
Weekly Report · 3d ago
Standard BioTools Amends Financials After SomaLogic Sale to Illumina
Reuters · 02/05 21:39
Standard BioTools veröffentlicht ergänzte Finanzinformationen nach Verkauf der SomaScan-Sparte
Reuters · 02/05 21:39
Illumina beats Q4 adjusted EPS estimates
Reuters · 02/05 21:16
More
About LAB
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Webull offers Standard Biotools Inc stock information, including NASDAQ: LAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LAB stock methods without spending real money on the virtual paper trading platform.